Literature DB >> 19711369

Regenerative medicine in the treatment of peripheral arterial disease.

Erica B Sneider1, Philip T Nowicki, Louis M Messina.   

Abstract

The last decade has witnessed a dramatic increase in the mechanistic understanding of angiogenesis and arteriogenesis, the two processes by which the body responds to obstruction of large conduit arteries. This knowledge has been translated into novel therapeutic approaches to the treatment of peripheral arterial disease, a condition characterized by progressive narrowing of lower extremity arteries and heretofore solely amenable to surgical revascularization. Clinical trials of molecular, genetic, and cell-based treatments for peripheral artery obstruction have generally provided encouraging results. (c) 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19711369     DOI: 10.1002/jcb.22315

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  16 in total

1.  Peripheral artery disease: current insight into the disease and its diagnosis and management.

Authors:  Jeffrey W Olin; Brett A Sealove
Journal:  Mayo Clin Proc       Date:  2010-07       Impact factor: 7.616

2.  Imaging the effect of receptor for advanced glycation endproducts on angiogenic response to hindlimb ischemia in diabetes.

Authors:  Yared Tekabe; Xiaoping Shen; Joane Luma; Drew Weisenberger; Shi Fang Yan; Roland Haubner; Ann Marie Schmidt; Lynne Johnson
Journal:  EJNMMI Res       Date:  2011-06-07       Impact factor: 3.138

3.  Clinical applications in molecular imaging.

Authors:  Carola Heneweer; Jan Grimm
Journal:  Pediatr Radiol       Date:  2010-12-03

4.  Detrimental effect of class-selective histone deacetylase inhibitors during tissue regeneration following hindlimb ischemia.

Authors:  Francesco Spallotta; Silvia Tardivo; Simona Nanni; Jessica D Rosati; Stefania Straino; Antonello Mai; Matteo Vecellio; Sergio Valente; Maurizio C Capogrossi; Antonella Farsetti; Julie Martone; Irene Bozzoni; Alfredo Pontecorvi; Carlo Gaetano; Claudia Colussi
Journal:  J Biol Chem       Date:  2013-07-07       Impact factor: 5.157

Review 5.  Diabetes-associated macrovascular complications: cell-based therapy a new tool?

Authors:  Maddalena Gili; Alberto Orsello; Sara Gallo; Maria Felice Brizzi
Journal:  Endocrine       Date:  2013-03-30       Impact factor: 3.633

6.  Isolation and intravenous injection of murine bone marrow derived monocytes.

Authors:  Martin Wagner; Helen Koester; Christian Deffge; Soenke Weinert; Johannes Lauf; Alexander Francke; Jerry Lee; R C Braun-Dullaeus; Joerg Herold
Journal:  J Vis Exp       Date:  2014-12-27       Impact factor: 1.355

7.  Critical limb ischemia.

Authors:  Andres Schanzer; Michael S Conte
Journal:  Curr Treat Options Cardiovasc Med       Date:  2010-04-14

Review 8.  Mesenchymal stem cells as a treatment for peripheral arterial disease: current status and potential impact of type II diabetes on their therapeutic efficacy.

Authors:  Jinglian Yan; Guodong Tie; Ting Yu Xu; Katharine Cecchini; Louis M Messina
Journal:  Stem Cell Rev Rep       Date:  2013-06       Impact factor: 5.739

9.  Congenic fine-mapping identifies a major causal locus for variation in the native collateral circulation and ischemic injury in brain and lower extremity.

Authors:  Robert Sealock; Hua Zhang; Jennifer L Lucitti; Scott M Moore; James E Faber
Journal:  Circ Res       Date:  2013-12-03       Impact factor: 17.367

10.  Revascularization of ischemic skeletal muscle by estrogen-related receptor-γ.

Authors:  Antonios Matsakas; Vikas Yadav; Sabina Lorca; Ronald M Evans; Vihang A Narkar
Journal:  Circ Res       Date:  2012-03-13       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.